← Back to Screener
Harvard Bioscience Inc (HBIO)
Price$5.91
Favorite Metrics
Price vs S&P 500 (26W)25.29%
Price vs S&P 500 (4W)11.80%
Market Capitalization$25.67M
All Metrics
P/CF (Annual)3.81x
Book Value / Share (Quarterly)$3.07
P/TBV (Annual)4.89x
Indicated Dividend (Annual)$0.00
Revenue Growth (3Y)-8.59%
Cash Flow / Share (Quarterly)$1.09
Price vs S&P 500 (YTD)-16.84%
Gross Margin (TTM)57.67%
Net Profit Margin (TTM)-65.51%
EPS (TTM)$-2.57
10-Day Avg Trading Volume0.10M
EPS Excl Extra (TTM)$-2.57
Revenue Growth (5Y)-3.25%
EPS (Annual)$-12.77
ROI (Annual)-114.31%
Gross Margin (Annual)57.67%
Net Profit Margin (5Y Avg)-18.07%
Cash / Share (Quarterly)$1.93
Revenue Growth QoQ (YoY)-3.34%
ROA (Last FY)-70.81%
Revenue Growth TTM (YoY)-8.06%
EBITD / Share (TTM)$-3.37
ROE (5Y Avg)-90.12%
Operating Margin (TTM)-57.55%
Cash Flow / Share (Annual)$1.09
P/B Ratio1.87x
P/B Ratio (Quarterly)2.17x
Net Income / Employee (Annual)$-0
EV / Revenue (TTM)0.61x
Net Interest Coverage (TTM)-10.67x
ROA (TTM)-71.33%
EV / EBITDA (TTM)20.93x
EPS Incl Extra (Annual)$-12.77
Current Ratio (Annual)2.20x
Quick Ratio (Quarterly)1.25x
3-Month Avg Trading Volume0.06M
52-Week Price Return44.95%
EV / Free Cash Flow (Annual)10.88x
Revenue / Employee (TTM)$0
Tangible BV / Share (Quarterly)$1.36
P/S Ratio (Annual)0.30x
Asset Turnover (Annual)1.08x
52-Week High$9.46
Operating Margin (5Y Avg)-13.36%
EPS Excl Extra (Annual)$-12.77
CapEx CAGR (5Y)10.13%
Tangible BV CAGR (5Y)-32.50%
26-Week Price Return29.28%
Quick Ratio (Annual)1.25x
13-Week Price Return-7.57%
Total Debt / Equity (Annual)2.61x
Current Ratio (Quarterly)2.20x
Enterprise Value$52.925
Revenue / Share Growth (5Y)49.11%
Asset Turnover (TTM)1.09x
Book Value / Share Growth (5Y)9.55%
Revenue / Employee (Annual)$0
Inventory Turnover (Annual)1.66x
Pretax Margin (Annual)-66.30%
Cash / Share (Annual)$1.93
3-Month Return Std Dev94.08%
Gross Margin (5Y Avg)57.39%
Net Income / Employee (TTM)$-0
EBITDA Interim CAGR (5Y)-71.12%
ROE (Last FY)-412.84%
Net Interest Coverage (Annual)-10.67x
EPS Basic Excl Extra (Annual)$-12.77
P/FCF (TTM)3.76x
Receivables Turnover (TTM)5.60x
EV / Free Cash Flow (TTM)10.88x
Total Debt / Equity (Quarterly)2.61x
EPS Incl Extra (TTM)$-2.57
Receivables Turnover (Annual)5.60x
ROI (TTM)-113.95%
P/S Ratio (TTM)0.30x
Pretax Margin (5Y Avg)-17.83%
Revenue / Share (Annual)$19.50
Tangible BV / Share (Annual)$1.36
Forward P/E24.70x
Free OCF CAGR (5Y)-9.87%
Price vs S&P 500 (52W)15.12%
Year-to-Date Return-14.20%
5-Day Price Return6.89%
EPS Normalized (Annual)$-12.77
ROA (5Y Avg)-17.96%
Net Profit Margin (Annual)-65.51%
Month-to-Date Return17.86%
Cash Flow / Share (TTM)$0.09
EBITD / Share (Annual)$-10.91
Operating Margin (Annual)-57.55%
LT Debt / Equity (Annual)2.61x
P/CF (TTM)3.81x
ROI (5Y Avg)-27.60%
LT Debt / Equity (Quarterly)2.61x
EPS Basic Excl Extra (TTM)$-2.57
P/TBV (Quarterly)4.89x
P/B Ratio (Annual)2.17x
Inventory Turnover (TTM)1.66x
Pretax Margin (TTM)-66.30%
Book Value / Share (Annual)$3.07
Price vs S&P 500 (13W)-8.26%
Beta1.46x
P/FCF (Annual)5.28x
Revenue / Share (TTM)$19.40
ROE (TTM)-388.56%
52-Week Low$2.81
Analyst Recommendations
Jan 2026
Feb 2026
Mar 2026
Apr 2026
4.00
4.00
4.00
4.00
Industry Peers — Lab Analytical Instruments(22)
| Symbol | P/S Ratio (TTM) | Revenue Growth (5Y) | Gross Margin (TTM) | Operating Margin (TTM) | Price |
|---|---|---|---|---|---|
HBIOHarvard Bioscience Inc | 0.30x | -3.25% | 57.67% | -57.55% | $5.91 |
AAgilent Technologies Inc. | 4.74x | 5.41% | 52.60% | 20.40% | $118.25 |
WATWaters Corp | 10.04x | 6.00% | 59.28% | 25.36% | $319.04 |
MTDMettler-Toledo International | 6.50x | 5.47% | 59.37% | 26.05% | $1290.84 |
ILMNIllumina Inc | 4.62x | 6.04% | 66.61% | 18.44% | $132.72 |
RVTYRevvity, Inc. | 3.64x | -5.46% | 54.77% | 12.49% | $89.53 |
BIOBio-Rad Laboratories, Inc.Class A | 3.06x | 0.29% | 52.01% | 1.59% | $291.09 |
BIO.BBio-Rad Laboratories, Inc. Class B | 3.06x | 0.29% | 52.01% | 1.59% | $277.00 |
BRKRPBruker Corporation 6.375% Mandatory Convertible Preferred Stock, Series A | 1.75x | 11.57% | 47.13% | 1.40% | $306.06 |
BRKRBruker Corporation | 1.73x | 11.57% | 47.13% | 1.40% | $38.94 |
AVTRAvantor, Inc. | 0.86x | 0.49% | 32.65% | -3.83% | $8.26 |
About
Harvard Bioscience designs and manufactures specialized instruments and products for life sciences research, pharmaceutical discovery, and drug development. The company serves customers globally through direct and distribution channels, with brands including Harvard Apparatus, DSI, Buxco, Biochrom, and others. Most revenue is generated in the United States, though the company maintains operations across North America, Europe, and China.